Therapeutic Drug Monitoring of Ganciclovir in Cytomegalovirus-Infected Patients With Solid Organ Transplants and Its Correlation to Efficacy and Toxicity

Cytomegalovirus causes morbidity and mortality, especially in immunocompromised patients, and is treated with (val)ganciclovir. Therapeutic drug monitoring of ganciclovir is often performed; however, clinically established target trough levels corresponding to efficacy are lacking. In 2021, our clin...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Wekken-Pas, Lena C., Totté, Joan, Lunel, Frans V., van Zuilen, Arjan, van Luin, Matthijs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Therapeutic Drug Monitoring 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351899/
https://www.ncbi.nlm.nih.gov/pubmed/36730727
http://dx.doi.org/10.1097/FTD.0000000000001054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351899/
https://www.ncbi.nlm.nih.gov/pubmed/36730727
http://dx.doi.org/10.1097/FTD.0000000000001054

Ejemplares similares